Bharat Parenterals Current Share Price | Bharat Parenterals Stock Screener
BPLPHARMA
Pharmaceuticals
Bharat Parenterals Current Stock Price Today
Live Share Price NSE
₹1533.30
▲
12.50 (0.82%)
Live Share Price BSE
₹1527.95
▼
-7.00 (-0.46%)
As of September 4, 2026, the live Bharat Parenterals share price (NSE: BPLPHARMA) is ₹1,533.30 on NSE and ₹1,527.95 on BSE, up 0.82% from the previous close, with shares trading between ₹1,520.00 and ₹1,568.80 in today's trading session, and a 52-week range of ₹1,264.80–₹1,541.20.
Browse BPLPHARMA annual financials to support your investment research.
Use the Bharat Parenterals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Bharat Parenterals Market Cap
₹842.19 Cr.
BPLPHARMA P/E Ratio (TTM)
15.00
Bharat Parenterals P/B Ratio
2.54
EPS (TTM)
₹-66.64
Dividend Yield
0.08%
Debt to Equity
0.64
BPLPHARMA 52 Week High
₹1541.20
Bharat Parenterals 52 Week Low
₹1264.80
Operating Margin
2.00%
Profit Margin
-8.49%
BPLPHARMA Revenue (TTM)
₹106.00
EBITDA
₹4.00
Net Income
₹-9.00
Total Assets
₹649.00
Total Equity
₹339.00
Bharat Parenterals Current Share Price Chart
Track the current Bharat Parenterals share price and stock price with an interactive chart. Analyse BPLPHARMA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Bharat Parenterals stock quote in one place.
Bharat Parenterals Company Profile - Fundamental Screener
Screen Bharat Parenterals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BPLPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE365Y01019
Bharat Parenterals Balance Sheet Screener
Screen BPLPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 649 | 504 | 350 | 226 | 199 | 188 | 159 | 132 | 111 | 120 |
| Current Assets | 356 | 260 | 184 | 144 | 148 | 132 | 118 | 91 | 64 | 72 |
| Fixed Assets | 252 | 210 | 42 | 41 | 45 | 33 | 35 | 34 | 31 | 35 |
| Liabilities | ||||||||||
| Total Liabilities | 649 | 504 | 350 | 226 | 199 | 188 | 159 | 132 | 111 | 120 |
| Current Liabilities | 90 | 75 | 13 | 14 | 11 | 3 | 4 | 2 | 4 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 339 | 238 | 218 | 170 | 144 | 118 | 94 | 73 | 64 | 57 |
| Share Capital | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 324 | 191 | 177 | 160 | 138 | 113 | 88 | 67 | 58 | 51 |
Bharat Parenterals Income Statement Screener - Profit & Revenue Analysis
Screen Bharat Parenterals income statement and profit fundamentals.
Analyze BPLPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bharat Parenterals share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106 | 117 | 68 | 71 | 95 | 76 | 75 | 51 | 72 | 62 | 61 | 55 | 28 | 88 | 63 |
| Expenses | 102 | 102 | 64 | 67 | 88 | 79 | 69 | 45 | 60 | 56 | 53 | 48 | 24 | 73 | 56 |
| EBITDA | 4 | 15 | 4 | 4 | 7 | -4 | 7 | 7 | 13 | 7 | 8 | 7 | 3 | 16 | 6 |
| Operating Profit % | 2.00% | 12.00% | 1.00% | 1.00% | 5.00% | -11.00% | 5.00% | 12.00% | 15.00% | 7.00% | 11.00% | 8.00% | 7.00% | 11.00% | 4.00% |
| Depreciation | 9 | 9 | 9 | 4 | 9 | 9 | 9 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Interest | 4 | 4 | 3 | 1 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| Profit Before Tax | -8 | 3 | -7 | -1 | -5 | -15 | -6 | 4 | 10 | 5 | 6 | 5 | 2 | 14 | 4 |
| Tax | 1 | 3 | 1 | 1 | 4 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 0 | 4 | 1 |
| Net Profit | -9 | -1 | -9 | -3 | -9 | -18 | -8 | 2 | 7 | 2 | 4 | 4 | 1 | 10 | 3 |
| EPS | -14.40 | -1.00 | -14.00 | -0.62 | -2.11 | -27.00 | -10.00 | 4.24 | 13.03 | 6.07 | 6.45 | 7.04 | 2.03 | 17.19 | 4.94 |
Bharat Parenterals Cash Flow Screener - Liquidity Fundamentals
Screen BPLPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -27 | -5 | 22 | -1 | 25 | 14 | 20 | 6 | -2 | 0 |
| Investing Activities | -137 | -105 | -78 | -7 | -43 | -13 | -9 | -8 | -2 | 0 |
| Financing Activities | 156 | 110 | 61 | 9 | 11 | -3 | -4 | 4 | -8 | 0 |
| Net Cash Flow | -8 | 1 | 4 | 2 | -8 | -1 | 7 | 2 | -11 | 0 |
Bharat Parenterals Shareholding Pattern Screener
See Bharat Parenterals shareholding pattern with promoter, FII, and DII holdings.
Check Bharat Parenterals promoter holding and ownership changes for BPLPHARMA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Oct | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 67.20% | 67.19% | 67.19% | 73.26% | 73.27% | 65.35% | 67.20% | 67.20% |
| FII Holding | 0.11% | 0.11% | 0.11% | 0.00% | 0.00% | 0.08% | 0.08% | 0.11% |
| DII Holding | 0.54% | 0.54% | 0.54% | 0.01% | 0.01% | 0.57% | 0.54% | 0.54% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.94% | 19.31% | 19.27% | 13.61% | 13.60% | 20.07% | 19.00% | 19.20% |
| Other Holding | 13.21% | 12.85% | 12.89% | 13.11% | 13.13% | 13.92% | 13.18% | 12.95% |
| Shareholder Count | 3,177 | 3,231 | 3,205 | 2,497 | 2,727 | 2,748 | 2,750 | 3,116 |
Bharat Parenterals Share Dividend Screener - Share Yield Analysis
Check Bharat Parenterals dividend history with payout and yield data.
View Bharat Parenterals dividend details including ex-dates and amounts for BPLPHARMA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.00 | 0.08% |
| 2024-March | ₹1.00 | 0.10% |
| 2023-March | ₹0.75 | 0.07% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Bharat Parenterals Stock Index Membership
See which indices include Bharat Parenterals stock.
Check BPLPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bharat Parenterals Market Events Screener - Corporate Actions
Get Bharat Parenterals corporate actions including splits, bonuses, and buybacks.
Check Bharat Parenterals stock events that may affect BPLPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -10.23% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -4.06% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 1.00 /share | 21.17% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | 10.26% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -7.55% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -5.87% |
| 2024-07-02 | 2024-07-02 | Annual General Meeting | NA | 6.46% |
| 2024-06-25 | 2024-06-25 | Dividend | ₹ 1.00 /share | -3.36% |
| 2024-05-21 | 2024-05-21 | Extraordinary General Meeting | NA | -11.42% |
| 2023-09-25 | 2023-09-25 | Dividend | ₹ 0.75 /share | 68.09% |
Bharat Parenterals Competitors Screener - Peer Comparison
Screen BPLPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Bharat Parenterals Company Announcements - News Screener
Screen BPLPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-12-09 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window. | - |
| 2025-12-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-25 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window. | - |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 | - |
| 2025-11-12 | For The Quarter And Half Year Ended September 30 2025 | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2025-11-12 | Board Meeting Outcome for For Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025. | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-06 | Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2025. | - |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |